Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001193805-04-000816
Filing Date
2004-05-18
Accepted
2004-05-18 18:20:16
Documents
2
Period of Report
2004-05-14

Document Format Files

Seq Description Document Type Size
1 e400510_ex.html 4/A  
1 e400510_ex.xml 4/A 9397
2 JOINT FILING INFORMATION e400510_ex99-1.txt EX-99.1 1420
  Complete submission text file 0001193805-04-000816.txt   13799
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FIRST NEW YORK SECURITIES, LLC 850 THIRD AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Reporting) CIK: 0001164426 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 04817116

Mailing Address
Business Address PERCEPTIVE CAPITAL 5437 CONNECTICUT AVENUE NW STE 100 WASHINGTON DC 20015 2025370029
PERCEPTIVE ADVISORS LLC (Reporting) CIK: 0001224962 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 04817117

Mailing Address 5437 CONNECTICUT AVE NW STE 100 WASHINGTON DC 20015
Business Address 5437 CONNECTICUT AVE NW STE 100 WASHINGTON DC 20015 2035370029
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) CIK: 0001249675 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 04817115